Core Viewpoint - The launch of the new generation all-femtosecond CLEAR Pro technology represents a significant advancement in the field of ophthalmology, particularly in refractive surgery, addressing the limitations of traditional platforms and enhancing personalized treatment options for astigmatism correction [1][20]. Group 1: Technology and Innovation - The CLEAR (Corneal Lens Extraction) technique allows for customized vision correction by analyzing individual corneal topography, astigmatism distribution, and higher-order aberrations, thus improving post-operative visual quality, especially at night [3][9]. - The Z8 device used in the CLEAR procedure features automatic lens positioning, significantly reducing vertical coma risk and achieving micron-level precision in positioning [9][10]. - The Z8 system's dual-tunnel guiding mechanism reduces intra-stromal operations by 40%, leading to a 35% decrease in inflammatory responses [10][12]. Group 2: Clinical Outcomes and Efficacy - Clinical data indicates that 90% of patients achieved 20/20 vision or better one month post-surgery, with 100% of patients within ±0.50D of equivalent spherical power, showcasing the advantages of the CLEAR procedure over other platforms [15]. - The CLEAR technique has demonstrated an 83% reduction in the incidence of coma aberrations and a 22% decrease in corneal tissue loss, highlighting its effectiveness [10][12]. Group 3: Market Position and Future Outlook - Ziemer, having focused on the lens extraction market for a decade, aims to leverage the CLEAR technology to address existing challenges and set new industry standards [7][17]. - The introduction of the CLEAR Pro technology is expected to enhance the accessibility and sophistication of refractive surgery, allowing more patients to benefit from improved vision correction solutions [20].

Group 1 - The first National Eye Health Science Popularization Seminar was held in Ningbo, focusing on myopia prevention and eye health education [1] - The theme of the seminar was "Focusing on Eye Health Science Education, Deepening Collaborative Innovation in Popularization" [1] - The Ningbo Eye Hospital emphasized the importance of eye health in national public health strategy and public health management [1] Group 2 - The seminar initiated the compilation of the "National Eye Health Popularization Guide," aiming to shift eye health education from "expert-led" to "public participation" [2] - Innovations in myopia prevention were shared, including a comprehensive approach combining traditional and Western medicine [2] - Ningbo Eye Hospital introduced the "Medical-School Myopia Prevention Circle" and a graded intervention system, achieving significant results in local schools [2] Group 3 - The seminar concluded with a consensus to integrate resources from various regions to enhance myopia prevention and eye health education efforts [3] - Participants visited local schools and the Ningbo Eye Health Science Popularization Museum to observe practical implementations [3]

Core Viewpoint - Aier Eye Hospital (300015) and a research team from Nankai University have achieved a significant breakthrough in treating dry eye syndrome related to Sjögren's syndrome through the development of a "ROS-responsive microneedle patch" [1] Group 1 - The research findings were published in the international academic journal "Advanced Science" [1] - The paper was selected as the cover article for Volume 12, Issue 16, scheduled for publication on April 24, 2025, due to its innovation and academic value [1] - This breakthrough offers new treatment hope for patients suffering from dry eye syndrome related to Sjögren's syndrome (SSDE) [1]

Group 1 - The core viewpoint of the articles highlights the performance and financial metrics of He Shi Eye Hospital Group, indicating a recent stock price increase and a decline in shareholder numbers [1][2] - As of May 16, the closing stock price of He Shi Eye Hospital was 20.78 yuan, up by 1.02%, with a latest price-to-book ratio of 1.72, marking a new low in 13 days and a total market capitalization of 3.284 billion yuan [1] - The company reported a revenue of 291 million yuan for Q1 2025, representing a year-on-year increase of 2.35%, and a net profit of 32.53 million yuan, which is a 12.27% increase year-on-year, with a gross profit margin of 43.80% [1] Group 2 - The company has 9,399 shareholders as of March 31, 2025, a decrease of 392 shareholders from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - He Shi Eye Hospital's main business focuses on personalized and intelligent eye health management services, including refractive surgery, cataract treatment, retinal disease treatment, and other eye disease treatments [1] - The company's price-to-earnings (P/E) ratio is significantly lower than the industry average, with a trailing P/E of -137.73 compared to the industry average of 37.33 [2]

普瑞眼科2025年第一季度报告显示，普瑞眼科报告期内营业总收入为7.42亿元，同比增长9.82%；归属 于上市公司股东的净利润为2727.94万元，同比增长61.18%；归属于上市公司股东的扣除非经常性损益 的净利润为2831.55万元，同比增长48.37%；经营活动产生的现金流量净额为1.95亿元。 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | | --- | --- | --- | --- | --- | | | | | (%) | | | 营业收入(元) | 742. 251. 316. 24 | 675,882,973,16 | | 9.82% | | 归属于上市公司股东的净利 | 27, 279, 356. 63 | 16, 924, 936, 43 | | 61. 18% | | 润(元) | | | | | | 归属于上市公司股东的扣除 非经常性损益的净利润 | 28, 315, 487, 26 | 19,084,077.60 | | 48. 37% | | (元) | | | | | | 经营活动产生的现金流量净 额(元) | 194. 676. 885. 40 | 12 ...

接到举报后，南通市纪委监委组成了工作专班，对相关问题进 行了全面彻查。目前，已依规依纪对有关涉事人员进行了严格 处理。 作者：张铃 封图：图虫创意 同时，艾芬亦对爱尔眼科员工提起过诉讼。艾芬曾起诉爱尔眼科职工段某民、刘某菲、刘某等侵犯 名誉权，2025年4月，武汉市江汉区人民法院一审判决艾芬胜诉 。 在该一审判决前后 ，艾芬的 微博账号"急诊向日葵艾芬"被封。 南通爱尔眼科医院是爱尔眼科（300015.SZ）旗下医院。爱尔眼科成立于2003年，是中国眼科龙 头，截至2024年底，爱尔眼科在全球范围内共有974家品牌医院、眼科中心及诊所，其中811家 在中国内地。此前，爱尔眼科董事长陈邦曾于2022年初发内部信，称将全面拥抱社会监督。 艾芬曾在抗击新冠疫情中作出积极贡献，民间评价其为"疫情发哨人"。2020年5月，艾芬因白内 障在武汉爱尔眼科医院进行了人工晶体植入手术，术后5个月出现右眼视网膜脱落，12月其申诉右 眼几乎失明，质疑医院存在违规操作。爱尔眼科则称，艾芬视网膜脱离与医院手术没有直接关联。 有关部门曾就该事件成立调查组，爱尔眼科称，艾芬不同意进行医疗鉴定、不走法律程序。 艾芬多次在社交平台质疑爱尔眼科 ...

Group 1 - On May 15, 2023, the CEO of Nantong Aier Eye Hospital, Yu Wenjuan, was given a disciplinary sanction by the Nantong Municipal Commission for Discipline Inspection, and her status as a member of the Political Consultative Conference was revoked [1] - The disciplinary action followed a report submitted by Ai Fen, the director of the emergency department at Wuhan Central Hospital, alleging that several public officials in Nantong accepted invitations to banquets hosted by Yu Wenjuan [1] - The Nantong Municipal Commission for Discipline Inspection formed a special task force to investigate the allegations, leading to strict disciplinary actions against the involved personnel [1] Group 2 - Aier Eye Hospital, part of Aier Eye Group (300015.SZ), is a leading eye care provider in China, with 974 hospitals and clinics globally, including 811 in mainland China as of the end of 2024 [2] - Ai Fen, known for her contributions during the COVID-19 pandemic, has raised concerns about the management and treatment practices at Aier Eye Hospital, particularly regarding her own medical experience [2] - Legal disputes have arisen between Ai Fen and Aier Eye employees, with multiple lawsuits filed over defamation, resulting in mixed outcomes in court [3]

投资者关系活动记录表 编号：2025-003 | | □特定对象调研 □分析师会议 □媒体采访 ☑业绩说明会 | | --- | --- | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 | | 参与单位名称及人员 | 通过全景网"投资者关系互动平台"（https://ir.p5w.net）参与 | | 姓名 | 厦门辖区上市公司 2024 年年报业绩说明会暨投资者网上集体 | | | 接待日活动的投资者 | | 时间 | 2025 年 5 月 15 日（周四）下午 15:40~17:00 | | 地点 | 全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 陈凤国先生 董事 | | | 陈鹭燕女士 财务总监 | | 上市公司接待人员 姓名 | 曹乃恩先生 董事会秘书 | | | 王志强先生 独立董事 | | | 赵 冀先生 保荐代表人 | | | 1、请问一下 年公司，持续发展和业务开展做了哪些调 25 | | | 整和创新？ | | | 尊敬的投资者您好，感谢您对华厦眼科的关注。从 2025 | | | 年起，公司将按照《华 ...

Core Insights - The company aims to build a "Smart City of Light" focusing on global eye health, leveraging a comprehensive ecosystem in the eye health industry and utilizing technologies like big data, AI, and stem cells for digital and holistic eye health management [1][2] - The company has integrated digital technology and AI with public welfare, establishing a broad grassroots eye care service network, enhancing accessibility and inclusivity of eye health services, and contributing to rural revitalization [2] - The company emphasizes practical and applicable technology to improve healthcare service efficiency, aiming to make technological innovations beneficial to the public and promote global eye health [3] Summary by Sections Company Strategy - The company is focused on creating a comprehensive eye health management service model that encompasses the entire lifecycle of patient care, utilizing advanced technologies for precision and smart healthcare [1] Technological Integration - The company has developed the "Smart Eye Health Management Station" and "Light House" projects, which utilize AI for early detection and intervention of eye diseases, significantly improving public health service accessibility [2] International Collaboration - The company actively participates in international blindness prevention efforts, providing training for ophthalmologists in developing countries, thereby enhancing global eye health capabilities [2] Recognition and Awards - The "Light House" project received a gold award for service model innovation at the first national social medical "New Quality Productivity" case competition in 2024 [2]

Core Insights - He Eye Hospital has been recognized for the second consecutive year for its significant contributions to the revitalization efforts in Liaoning Province in 2024 [2] - The hospital focuses on technological innovation to enhance its development capabilities and service quality, aiming for a transformation towards intelligent, precise, and inclusive eye health services [2] - The hospital is committed to the "Healthy China" strategy and aims to build a "Smart Bright City" by leveraging its unique advantages in the eye health industry chain [2] Group 1 - He Eye Hospital has established a "365 Myopia Prevention System" to improve vision health among children and adolescents in Liaoning Province [2] - The hospital integrates digital technology and artificial intelligence with public welfare, creating a broad grassroots eye care service network across Liaoning [3] - The "Bright House" project has won a gold award for service model innovation at the 2024 National First Social Medical "New Quality Productivity" Case Competition [3] Group 2 - He Eye Hospital actively responds to the "Belt and Road" initiative by providing capacity building for ophthalmologists in over ten countries, training more than 120 eye doctors and optometrists [3] - The hospital has hosted several international academic exchange events to deepen domestic and international academic collaboration in the field of ophthalmology [4] - Events include the "China-Japan-Korea Eye Health Innovation Technology Academic Exchange" and the "2024 International Genomics Conference Eye Conference," promoting global knowledge sharing in eye care [4]